country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-155594

Copy Link Print Information

LT-540-717

LT-540-717 (compound 32) is a potent FLT3 inhibitor (IC₅₀=0.62 nM) with antiproliferative activity. LT-540-717 also inhibits several acquired FLT3 mutations, FLT3 (ITD, D835V), FLT3 (ITD, F691L), FLT3 (D835Y) and FLT3 (D835V). LT-540-717 has potential to be an anti-AML agent.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 2143089-35-2
分子式: C₂₄H₂₄N₈O₂
分子量:456.50

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (268 KB)

LT-540-717 構造式

CAS 番号: 2143089-35-2

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
ACHN	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human ACHN cells assessed as inhibition of cell growth Antiproliferative activity against human ACHN cells assessed as inhibition of cell growth	[PMID: 37163951]
BaF3	IC₅₀	0.009 μM Compound: 32; LT-540-717	Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/D835V mutant assessed as inhibition of cell growth incubated for 72 hrs Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/D835V mutant assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
BaF3	IC₅₀	0.039 μM Compound: 32; LT-540-717	Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth incubated for 72 hrs Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
BaF3	IC₅₀	0.043 μM Compound: 32; LT-540-717	Antiproliferative activity against mouse BaF3 cells harboring FLT3 D835V mutant assessed as inhibition of cell growth incubated for 72 hrs Antiproliferative activity against mouse BaF3 cells harboring FLT3 D835V mutant assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
BaF3	IC₅₀	0.054 μM Compound: 32; LT-540-717	Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/N676D mutant assessed as inhibition of cell growth incubated for 72 hrs Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/N676D mutant assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
BaF3	IC₅₀	0.095 μM Compound: 32; LT-540-717	Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/F691L mutant assessed as inhibition of cell growth incubated for 72 hrs Antiproliferative activity against mouse BaF3 cells harboring FLT3 ITD/F691L mutant assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
BaF3	IC₅₀	2.922 μM Compound: 32; LT-540-717	Cytotoxicity against mouse BaF3 cells assessed as inhibition of cell growth incubated for 72 hrs Cytotoxicity against mouse BaF3 cells assessed as inhibition of cell growth incubated for 72 hrs	[PMID: 37163951]
HL-60	IC₅₀	972.1 nM Compound: 32; LT-540-717	Antiproliferative activity against human HL-60 cells expressing low level wild type FLT3 assessed as inhibition of cell growth Antiproliferative activity against human HL-60 cells expressing low level wild type FLT3 assessed as inhibition of cell growth	[PMID: 37163951]
K562	IC₅₀	572.1 nM Compound: 32; LT-540-717	Antiproliferative activity against human K562 cells deficit of oncogenic FLT3 assessed as inhibition of cell growth Antiproliferative activity against human K562 cells deficit of oncogenic FLT3 assessed as inhibition of cell growth	[PMID: 37163951]
KM12	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human KM12 cells assessed as inhibition of cell growth Antiproliferative activity against human KM12 cells assessed as inhibition of cell growth	[PMID: 37163951]
LOX IMVI	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human LOX IMVI cells assessed as inhibition of cell growth Antiproliferative activity against human LOX IMVI cells assessed as inhibition of cell growth	[PMID: 37163951]
MOLM-13	IC₅₀	16.3 nM Compound: 32; LT-540-717	Antiproliferative activity against human MOLM-13 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth Antiproliferative activity against human MOLM-13 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth	[PMID: 37163951]
MV4-11	IC₅₀	0.015 μM Compound: 32; LT-540-717	Antiproliferative activity against human MV4-11 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent assay Antiproliferative activity against human MV4-11 cells harboring FLT3 ITD mutant assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent assay	[PMID: 37163951]
NCI-H460	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth	[PMID: 37163951]
PBMC	IC₅₀	831.3 nM Compound: 32; LT-540-717	Cytotoxicity against human PBMC cells assessed as inhibition of cell growth Cytotoxicity against human PBMC cells assessed as inhibition of cell growth	[PMID: 37163951]
SR	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human SR cells assessed as inhibition of cell growth Antiproliferative activity against human SR cells assessed as inhibition of cell growth	[PMID: 37163951]
SR	GI₅₀	0.3 μM Compound: 32; LT-540-717	Antiproliferative activity against human SR cells not addicted to FLT3 ITD mutant assessed as inhibition of cell growth Antiproliferative activity against human SR cells not addicted to FLT3 ITD mutant assessed as inhibition of cell growth	[PMID: 37163951]
SW-620	GI₅₀	<1 μM Compound: 32; LT-540-717	Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth	[PMID: 37163951]
THP-1	IC₅₀	903.5 nM Compound: 32; LT-540-717	Antiproliferative activity against human THP-1 cells expressing wild type FLT3 assessed as inhibition of cell growth Antiproliferative activity against human THP-1 cells expressing wild type FLT3 assessed as inhibition of cell growth	[PMID: 37163951]
U-937	IC₅₀	692.3 nM Compound: 32; LT-540-717	Antiproliferative activity against human U-937 cells expressing low level wild type FLT3 assessed as inhibition of cell growth Antiproliferative activity against human U-937 cells expressing low level wild type FLT3 assessed as inhibition of cell growth	[PMID: 37163951]

化学情報

CAS 番号 2143089-35-2
分子量 456.50
分子式 C₂₄H₂₄N₈O₂
SMILES

O=C(NC1=CC=C(N2CCNCC2)C=C1)C3=NNC=C3NC4=NC=NC(OC5=CC=CC=C5)=C4
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (268 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Zhi Y, et al. Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor. Eur J Med Chem. 2023 Aug 5;256:115448. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ